Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment

Fig. 5

CDEs-based liquid biopsy strategies for cancer diagnostic applications. Considered the facts that CAFs-derived exosomal-packed biomolecules fully reflect the current tumor status, CDEs-based liquid biopsy are optimal minimally invasive detection indicators for cancer diagnosis, therapeutic efficacy assessment, and prognosis evaluation. By collecting the CDEs and detecting contained bioactive molecules from blood or other body fluids, we could not only enhance the patient compliance, but also improve the detectable rate combined with other detection indicators for early diagnosis

Back to article page

Molecular Medicine

ISSN: 1528-3658